CMC Bioanalytics

GxP Compliant CMC Bioanalytics for All Stages of Product Development

The Catalytic Intelligence Platform integrates purpose-built bioinformatic pipelines with Al-powered workflows to streamline CMC characterization and regulatory submissions for complex biologic therapies.

No-code GXP Compliant Analysis and Reporting

catalytic
1. Pre-processing & Quality Control

Analytics covering automated read trimming, read brimming, global alignment and local realignments

2. Variant Detection and Analysis

Comprehensive suite of bioinformatic pipelines covering detection of single nucleotide variants, short inDel variants, structural variants, large-scale InDels, and off-target edits for CRISPR, TALEN, ZFN, meganucleases, and custom endonucleases

3. Functional and Clinical Interpretation

Automated annotation pipelines that identify the functional impact of edits and genomic insertions on molecular and cellular processes and the clinical relevance of edits to safety and efficacy.

4. Automated Report Generation

Customizable Al Agents integrated with analytic and bioinformatic pipelines receive input data and draft written reports for regulatory submissions

5. CMC Analytics Hub

Rapidly access and integrate new capabilities from 500 analytics and pipelines in our Analytics Hub covering whole genome, whole exome, bulk RNA-seq, single cell RNA-seq, proteomics, metabalomics and flow cytometry workflows

Prevent Costly Regulatory Delays

Stay Ahead of Evolving Guidance

Catalytic's intelligent Al Agents detect, mine and report on newly issued guidance documents and AdComm meetings to identify changing regultory sentiment so partners stay ahead of upcoming requirements

Avoid IND Delays

Catalytic's suite of capabilities enabled a partner to quickly add integration site analyses and functional annotation of off target edits resolving FDA concerns and preventing an IND delay.

Lift Clinical Holds

Catalytic's suite of capabilities enabled a partner to demonstrate a detected chromosomal abnormality in a clinical tial participant was not related to an editing event resolving a clinical hold in 90 days.

Strengthen Release Criteria

Catalytic's CMC Analytics Hub enabled a partner to seamlessly add structural variant and copy number vanant analyses to meet evolving release criteria requirements

Dickens, Ribosomes, and the Need for Better Research Informatics

Stay Ahead of Evolving Guidance

Intelligent Al agents monitor and analyze newly issued guidance documents and AdComm meetings to detect shifts in regulatory sentiment, helping partners stay ahead of emerging trends and potential changes.

Dickens, Ribosomes, and the Need for Better Research Informatics

Avoid IND Delays

With over 300 plug and play bioinformatic pipelines and analytic tools, you can rapidly add capabilities requested during INTERACT meetings without having to develop new solutions or outsource critical work.

Dickens, Ribosomes, and the Need for Better Research Informatics

Lift Clinical Holds

Adverse events are often unpredictable in early trials. Having access to a comprehensive library of analytic solutions and an experienced team at Catalytic enables you to promptly deliver the analysis regulators need to release holds.

Dickens, Ribosomes, and the Need for Better Research Informatics

Strengthen Release Criteria

Lockable analytic pipelines paired with detailed technical documentation, run-time metadata, version control, and full audit trails provide the transparency needed to support confident batch release, deviation management, and regulatory compliance.